CPI-203
CPI-203 is a primary amide analog of (+) -JQ1, which has shown superior bioavailability with oral or i.p. administration. CPI-203 downregulates Myc expression, causes G1 cell cycle arrest and attenuates cell proliferation in human pancreatic neuroendocrine tumors. CPI-203 also arrests the growth of T cell acute lymphoblastic leukemia cells in vitro (EC50= 91.2 nM) .
Product Specifications
Format
Solid
Molecular Formula
C19H18ClN5OS
Shipping Conditions
Room Temperature
Storage Conditions
At least 6 months at -20°C.
Calculated Molecular Weight
399.9 Da
CAS Number
1446144-04-2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1253304-01 0.02 mg (E-Coli)
Recombinant Thioalkalivibrio sp. Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC)
Ask
View Details 
MBS1253304-02 0.02 mg (Yeast)
Recombinant Thioalkalivibrio sp. Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC)
Ask
View Details MBS1253304-03 0.1 mg (E-Coli)
Recombinant Thioalkalivibrio sp. Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC)
Ask
View Details 
MBS1253304-04 0.1 mg (Yeast)
Recombinant Thioalkalivibrio sp. Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC)
Ask
View Details MBS1253304-05 0.02 mg (Baculovirus)
Recombinant Thioalkalivibrio sp. Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC)
Ask
View Details